Benzydamine
CAS No. 642-72-8
Benzydamine ( —— )
Catalog No. M22988 CAS No. 642-72-8
Benzydamine is a benzyl-indazole having analgesic, antipyretic, and anti-inflammatory effects.?Benzydamine is used to reduce post-surgical and post-traumatic pain and edema and to promote healing.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 45 | In Stock |
|
50MG | 106 | In Stock |
|
100MG | 160 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBenzydamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionBenzydamine is a benzyl-indazole having analgesic, antipyretic, and anti-inflammatory effects.?Benzydamine is used to reduce post-surgical and post-traumatic pain and edema and to promote healing.
-
DescriptionBenzydamine is a benzyl-indazole having analgesic, antipyretic, and anti-inflammatory effects.?Benzydamine is used to reduce post-surgical and post-traumatic pain and edema and to promote healing.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number642-72-8
-
Formula Weight309.4
-
Molecular FormulaC19H23N3O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCN(C)CCCOC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.N P Singh, J K Makkar, V Wourms, P M Singh.Topical benzydamine for preventing postoperative sore throat.Anaesthesia. 2018 Oct;73(10):1297.
molnova catalog
related products
-
MCI-225
MCI-225 is a selective inhibitor of NA reuptake with 5-HT3 receptor antagonism.MCI-225 (10 mg/kg, po) showed comparable anxiolytic-like effect between single and 5-day repeated administration.?
-
β-Casomorphin (1-5),...
β-Casomorphin Fragment 1-5 (BCM5), an opioid receptor agonist, is a member of the β-casomorphin peptide family derived from β-casein. β-casomorphins are used to study their differential effects on processes such as hyperglycemia, oxidative stress, opioid signalling and immunosuppression.
-
TC 14012
CXCR4 antagonist and ACKR3 (CXCR7) agonist (EC50 = 350 nM for CXCR7).